Agreements made to research potential new drugs may include:1. Research Collaboration Agreements: These are agreements between a pharmaceutical company and a research organization, such as a university or a government agency. The agreement outlines the terms and conditions of the collaboration, including the roles and responsibilities of each party, confidentiality requirements, and intellectual property rights.2. Licensing Agreements: These agreements give a pharmaceutical company the right to use or commercialize a new drug discovered by a research organization. The agreement outlines the terms and conditions of the license, including royalties and other financial considerations.3. Material Transfer Agreements: These agreements govern the transfer of biological materials, such as cell lines or tissues, from one party to another for research purposes. The agreement outlines the terms and conditions of the transfer, including any restrictions on the use of the materials and confidentiality requirements.4. Clinical Trial Agreements: These agreements are signed between a pharmaceutical company and a clinical research organization to conduct clinical trials on new drugs. The agreement outlines the terms and conditions of the clinical trial, including the protocol, timelines, and financial considerations.5. Cooperative Research and Development Agreements (CRADAs): These agreements are signed between a pharmaceutical company and a government agency, such as the National Institutes of Health (NIH), to develop new drugs. The agreement outlines the terms and conditions of the collaboration, including the roles and responsibilities of each party, intellectual property rights, and financial considerations.